Signal Transduction and Targeted Therapy
Note: The following journal information is for reference only. Please check the journal website for updated information prior to submission.
Journal Title
Signal Transduction and Targeted Therapy
SIGNAL TRANSDUCT TAR
ISSN / eISSN
2095-9907 / 2059-3635
Aims and Scope
Signal Transduction and Targeted Therapy (ISSN 2059-3635 (online), ISSN 2095-9907 (print), CN 51-1758/R) is a new open access journal, which aims to accomplish timely publication of the latest discoveries and progress in both basic science and clinical research related to signal transduction and targeted therapy. It will include research on major human diseases, including but not limited to: cancer, cardiovascular diseases, autoimmune diseases, and nervous system diseases.
Subject Area
BIOCHEMISTRY & MOLECULAR BIOLOGY
CELL BIOLOGY
CiteScore
44.50
View Trend
CiteScore Ranking
Category | Quartile | Rank |
---|---|---|
Biochemistry, Genetics and Molecular Biology - Genetics | Q1 | #2/347 |
Biochemistry, Genetics and Molecular Biology - Cancer Research | Q1 | #5/230 |
Web of Science Core Collection
Science Citation Index Expanded (SCIE) | Social Sciences Citation Index (SSCI) |
---|---|
Indexed | - |
Category (Journal Citation Reports 2024) | Quartile |
---|---|
BIOCHEMISTRY & MOLECULAR BIOLOGY | Q1 |
CELL BIOLOGY | Q1 |
Country/Area of Publication
United Kingdom
Publisher
Springer Nature
Year Publication Started
2016
Annual Article Volume
272
Open Access
YES
Contact
CAMPUS, 4 CRINAN ST, LONDON, ENGLAND, N1 9XW
Verified Reviews
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now